A team of researchers in the US has conducted an initial experimental trial with 20 subjects to demonstrate that immunization ...

A new vaccine trial conducted on humans for pancreatic cancer, one of the deadliest malignancies in the world, showed immense ...

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer that is often diagnosed at advanced stages and carries a low ...

Pancreatic cancer can be a silent killer, especially for people who inherit mutant genes that greatly raise their risk for ...

Scientists are developing a first-of-its-kind vaccine to prevent the disease in people at high risk. The project just reached an important milestone. A phase 1 clinical trial showed that an ...

A novel oral vaccine platform using genetically engineered Bifidobacterium could enhance anti-tumor immunity. In an exploratory phase I clinical study, the vaccine was well tolerated and generated ...

A first-in-human KRAS-targeted pancreatic cancer vaccine elicited durable immune responses in 90% of participants, and slowed precancerous lesions.

An investigational vaccine that targets common KRAS mutations induced durable immune responses among individuals at high risk ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its two clinical-stage immunotherapy ...

A diagnosis of pancreatic cancer is devastating news. Though it makes up only about 3% of cancers in the United States, it's one of the deadliest, and on track for a dark achievement: By 2030, it's ...

The landscape of cancer immunotherapies is evolving rapidly. Although peptides or mRNA vaccines encapsulated in lipid nanoparticles are the most popular platform for personalized cancer vaccines (PVCs ...